The Experts below are selected from a list of 327 Experts worldwide ranked by ideXlab platform
Alexis A Dieter - One of the best experts on this subject based on the ideXlab platform.
-
polyethylene glycol 3350 and Docusate Sodium compared with Docusate Sodium alone after urogynecologic surgery a randomized controlled trial
Obstetrical & Gynecological Survey, 2016Co-Authors: Autumn L Edenfield, Nazema Y Siddiqui, Jennifer M Wu, Alexis A DieterAbstract:(ed from Obstet Gynecol 2016;128:543–549) Patients who undergo pelvic reconstruction are at high risk of constipation following surgery due to use of narcotics, anesthesia, mechanical bowel preparations, and anatomic manipulation. Few rigorous studies have compared the efficacy of medications for the management of postoperative constipation after urogynecologic surgery.
-
polyethylene glycol 3350 and Docusate Sodium compared with Docusate Sodium alone after urogynecologic surgery a randomized controlled trial
Obstetrics & Gynecology, 2016Co-Authors: Autumn L Edenfield, Nazema Y Siddiqui, Jennifer M Wu, Alexis A Dieter, Melissa A GarrettAbstract:OBJECTIVE:To compare time to first bowel movement and additional gastrointestinal outcomes between women receiving polyethylene glycol 3350 (PEG3350) and Docusate Sodium and Docusate Sodium alone after urogynecologic surgery.METHODS:Participants received twice-daily 100 mg Docusate Sodium and were r
Nazema Y Siddiqui - One of the best experts on this subject based on the ideXlab platform.
-
polyethylene glycol 3350 and Docusate Sodium compared with Docusate Sodium alone after urogynecologic surgery a randomized controlled trial
Obstetrical & Gynecological Survey, 2016Co-Authors: Autumn L Edenfield, Nazema Y Siddiqui, Jennifer M Wu, Alexis A DieterAbstract:(ed from Obstet Gynecol 2016;128:543–549) Patients who undergo pelvic reconstruction are at high risk of constipation following surgery due to use of narcotics, anesthesia, mechanical bowel preparations, and anatomic manipulation. Few rigorous studies have compared the efficacy of medications for the management of postoperative constipation after urogynecologic surgery.
-
polyethylene glycol 3350 and Docusate Sodium compared with Docusate Sodium alone after urogynecologic surgery a randomized controlled trial
Obstetrics & Gynecology, 2016Co-Authors: Autumn L Edenfield, Nazema Y Siddiqui, Jennifer M Wu, Alexis A Dieter, Melissa A GarrettAbstract:OBJECTIVE:To compare time to first bowel movement and additional gastrointestinal outcomes between women receiving polyethylene glycol 3350 (PEG3350) and Docusate Sodium and Docusate Sodium alone after urogynecologic surgery.METHODS:Participants received twice-daily 100 mg Docusate Sodium and were r
Melissa A Garrett - One of the best experts on this subject based on the ideXlab platform.
-
polyethylene glycol 3350 and Docusate Sodium compared with Docusate Sodium alone after urogynecologic surgery a randomized controlled trial
Obstetrics & Gynecology, 2016Co-Authors: Autumn L Edenfield, Nazema Y Siddiqui, Jennifer M Wu, Alexis A Dieter, Melissa A GarrettAbstract:OBJECTIVE:To compare time to first bowel movement and additional gastrointestinal outcomes between women receiving polyethylene glycol 3350 (PEG3350) and Docusate Sodium and Docusate Sodium alone after urogynecologic surgery.METHODS:Participants received twice-daily 100 mg Docusate Sodium and were r
Autumn L Edenfield - One of the best experts on this subject based on the ideXlab platform.
-
polyethylene glycol 3350 and Docusate Sodium compared with Docusate Sodium alone after urogynecologic surgery a randomized controlled trial
Obstetrical & Gynecological Survey, 2016Co-Authors: Autumn L Edenfield, Nazema Y Siddiqui, Jennifer M Wu, Alexis A DieterAbstract:(ed from Obstet Gynecol 2016;128:543–549) Patients who undergo pelvic reconstruction are at high risk of constipation following surgery due to use of narcotics, anesthesia, mechanical bowel preparations, and anatomic manipulation. Few rigorous studies have compared the efficacy of medications for the management of postoperative constipation after urogynecologic surgery.
-
polyethylene glycol 3350 and Docusate Sodium compared with Docusate Sodium alone after urogynecologic surgery a randomized controlled trial
Obstetrics & Gynecology, 2016Co-Authors: Autumn L Edenfield, Nazema Y Siddiqui, Jennifer M Wu, Alexis A Dieter, Melissa A GarrettAbstract:OBJECTIVE:To compare time to first bowel movement and additional gastrointestinal outcomes between women receiving polyethylene glycol 3350 (PEG3350) and Docusate Sodium and Docusate Sodium alone after urogynecologic surgery.METHODS:Participants received twice-daily 100 mg Docusate Sodium and were r
Kirit A Shah - One of the best experts on this subject based on the ideXlab platform.
-
high performance liquid chromatographic analysis of Docusate Sodium in soft gelatin capsules
Journal of Pharmaceutical Sciences, 1992Co-Authors: David R Hogue, Joseph A Zimmardi, Kirit A ShahAbstract:A rapid and simple high‐performance liquid Chromatographic (HPLC) method for the analysis of Docusate Sodium in soft gelatin capsules was developed with progesterone as the internal standard. The method requires a reversed‐phase column and a pairedion technique to separate Docusate Sodium from other components. A C22 column was used with a mobile phase of acetonitrile: water (70:30) containing 0.005 M tetrabutylammonium phosphate. The flow rate was 1.8 mL/min, and the effluent was monitored at 214 nm. Docusate Sodium and progesterone had retention times of 4.5 and 6.8 min, respectively. The proposed HPLC method is linear, accurate, and precise. A mean assay value of 99.6% was obtained by the proposed method when five samples, each containing a composite of 10 capsules, were analyzed. The results obtained by the proposed HPLC, tetra‐n‐butylammonium iodide titration, and DSP XXII HPLC methods are compared.
-
High‐performance Liquid Chromatographic Analysis of Docusate Sodium in Soft Gelatin Capsules
Journal of Pharmaceutical Sciences, 1992Co-Authors: David R Hogue, Joseph A Zimmardi, Kirit A ShahAbstract:A rapid and simple high‐performance liquid Chromatographic (HPLC) method for the analysis of Docusate Sodium in soft gelatin capsules was developed with progesterone as the internal standard. The method requires a reversed‐phase column and a pairedion technique to separate Docusate Sodium from other components. A C22 column was used with a mobile phase of acetonitrile: water (70:30) containing 0.005 M tetrabutylammonium phosphate. The flow rate was 1.8 mL/min, and the effluent was monitored at 214 nm. Docusate Sodium and progesterone had retention times of 4.5 and 6.8 min, respectively. The proposed HPLC method is linear, accurate, and precise. A mean assay value of 99.6% was obtained by the proposed method when five samples, each containing a composite of 10 capsules, were analyzed. The results obtained by the proposed HPLC, tetra‐n‐butylammonium iodide titration, and DSP XXII HPLC methods are compared.